The global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the estimated period from 2022 to 2030.
The mechanism of action of opioid analgesics through binding to the mu, delta, and kappa receptors present in the brain by crossing the blood-brain barrier and giving the desired analgesic effect to treat non-cancer pain. In addition, the opioids bind to the mu receptors present in the gastrointestinal tract, which result in a contraction of the smooth muscles and alter the peristaltic movement causing constipation. Usually, the patients opt for over the counter osmotic laxatives and stimulant cathartics, which have been beneficial in providing relief from constipation in patients taking opioid analgesics for 3-4 weeks. In patients seeking palliative care, doctors prescribe mu-receptor antagonists and prostaglandin derivatives to cure opioid induced constipation.
In the present scenario, prescribed drugs are dominating the market on account of an increasing number of patients showing resistance to over-the-counter laxatives and cathartics. Moreover, opioid analgesics binds to the mu receptors of the gastrointestinal tract causing severe contraction of smooth muscles, altering the peristaltic activity of the gut motility, thus leading to chronic constipation. Physicians usually prescribe branded drugs such as methylnaltrexone bromide and naloxegol (mu-receptor antagonists) and prostaglandin derivatives such as lubiprostone to gain immediate relief from constipation by increasing fluid retention and stool softening. Over the counter (OTC) osmotic laxatives and stimulant cathartics are the drugs of the first choice by the patients to treat constipation. OTC products have shown good results in patients taking opioid analgesics for less than 4 weeks.
In addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more number of people staying at home. Hence, a sedentary lifestyle has resulted in the development of opioid induced constipation. In addition, irrational intake of OTC drugs and lack of physical activity will further aggravate the occurrence of opioid induced constipation in the elderly population
This report is a comprehensive research study of the global opioid induced constipation drugs market that elaborates the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of the global opioid induced constipation drugs market segmenting market by drug types and geography. This report aids the market stakeholders to make improved decisions and strategies in the opioid induced constipation drugs market.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The mechanism of action of opioid analgesics through binding to the mu, delta, and kappa receptors present in the brain by crossing the blood-brain barrier and giving the desired analgesic effect to treat non-cancer pain. In addition, the opioids bind to the mu receptors present in the gastrointestinal tract, which result in a contraction of the smooth muscles and alter the peristaltic movement causing constipation. Usually, the patients opt for over the counter osmotic laxatives and stimulant cathartics, which have been beneficial in providing relief from constipation in patients taking opioid analgesics for 3-4 weeks. In patients seeking palliative care, doctors prescribe mu-receptor antagonists and prostaglandin derivatives to cure opioid induced constipation.
In the present scenario, prescribed drugs are dominating the market on account of an increasing number of patients showing resistance to over-the-counter laxatives and cathartics. Moreover, opioid analgesics binds to the mu receptors of the gastrointestinal tract causing severe contraction of smooth muscles, altering the peristaltic activity of the gut motility, thus leading to chronic constipation. Physicians usually prescribe branded drugs such as methylnaltrexone bromide and naloxegol (mu-receptor antagonists) and prostaglandin derivatives such as lubiprostone to gain immediate relief from constipation by increasing fluid retention and stool softening. Over the counter (OTC) osmotic laxatives and stimulant cathartics are the drugs of the first choice by the patients to treat constipation. OTC products have shown good results in patients taking opioid analgesics for less than 4 weeks.
In addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more number of people staying at home. Hence, a sedentary lifestyle has resulted in the development of opioid induced constipation. In addition, irrational intake of OTC drugs and lack of physical activity will further aggravate the occurrence of opioid induced constipation in the elderly population
Regional Analysis
North America currently leads the opioid induced constipation drugs market due to the increasing number of patients suffering from non-cancer pain and rising public health awareness resulting in early diagnosis and treatment for osteoarthritis and rheumatoid arthritis. The European opioid induced constipation drugs market is driven by an increasing number of patients seeking palliative care in rehabilitation centers and the rising geriatric population suffering from non-cancer pain. The Asia Pacific is set to register significant growth in opioids induced constipation drugs market on account of the huge population base suffering from chronic diseases such as rheumatoid arthritis and fibromyalgia associated with strenuous working conditions. Rising use of opioids due to easy availability and poor regulation drives the Asia Pacific opioids induced constipation drugs market.This report is a comprehensive research study of the global opioid induced constipation drugs market that elaborates the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of the global opioid induced constipation drugs market segmenting market by drug types and geography. This report aids the market stakeholders to make improved decisions and strategies in the opioid induced constipation drugs market.
Historical - Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Opioid Induced Constipation Drugs market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Opioid Induced Constipation Drugs market and their expected impact during the forecast period.
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Opioid Induced Constipation Drugs market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Opioid Induced Constipation Drugs market?
- Which is the largest regional market for Opioid Induced Constipation Drugs market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East - Africa?
- Which are the key trends driving Opioid Induced Constipation Drugs market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Opioid Induced Constipation Drugs market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Opioid Induced Constipation Drugs Market
2.2. Global Opioid Induced Constipation Drugs Market, By Drug Type, 2021 (US$ Million)
2.3. Global Opioid Induced Constipation Drugs Market, By Prescription Type, 2021 (US$ Million)
2.4. Global Opioid Induced Constipation Drugs Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Opioid Induced Constipation Drugs Market Vendors
2.7.2. Strategies Adopted by Opioid Induced Constipation Drugs Market Vendors
2.7.3. Key Industry Strategies
2.7.4. Tier Analysis 2021 Versus 2030
2.8. Key Buying Criteria
2.9. Key Case Reports
2.10. Scenario Analysis
2.10.1. Optimistic estimates and analysis
2.10.2. Realistic estimates and analysis
2.10.3. Pessimistic estimates and analysis
2.11. Market Profiling
2.12. Sales and Marketing Plan
2.13. Top Market Conclusions
2.14. Strategic Recommendations
3. Opioid Induced Constipation Drugs Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Opioid Induced Constipation Drugs Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Methylnaltrexone Bromide
4.3.2. Lubiprostone
4.3.3. Naloxegol
4.3.4. Naldemedine
4.3.5. Docusate Sodium
4.3.6. Others5. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Prescribed
5.3.1.1. Branded
5.3.1.2. Generic
5.3.2. Over the Counter (OTC)
6. North America Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4. Opioid Induced Constipation Drugs Market: By Region, 2020-2030, USD (Million)
6.4.1. North America
6.4.1.1. U.S.
6.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4.1.2. Canada
6.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
6.4.1.3. Rest of North America
6.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7. UK and European Union Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4. Opioid Induced Constipation Drugs Market: By Region, 2020-2030, USD (Million)
7.4.1. UK and European Union
7.4.1.1. UK
7.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.2. Germany
7.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.3. Spain
7.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.4. Italy
7.4.1.4.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.4.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.5. France
7.4.1.5.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.5.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
7.4.1.6. Rest of Europe
7.4.1.6.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.6.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8. Asia Pacific Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4. Opioid Induced Constipation Drugs Market: By Region, 2020-2030, USD (Million)
8.4.1. Asia Pacific
8.4.1.1. China
8.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.2. Japan
8.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.3. India
8.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.4. Australia
8.4.1.4.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.4.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.5. South Korea
8.4.1.5.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.5.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
8.4.1.6. Rest of Asia Pacific
8.4.1.6.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.6.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9. Latin America Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4. Opioid Induced Constipation Drugs Market: By Region, 2020-2030, USD (Million)
9.4.1. Latin America
9.4.1.1. Brazil
9.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4.1.2. Mexico
9.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
9.4.1.3. Rest of Latin America
9.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10. Middle East and Africa Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4. Opioid Induced Constipation Drugs Market: By Region, 2020-2030, USD (Million)
10.4.1. Middle East and Africa
10.4.1.1. GCC
10.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4.1.2. Africa
10.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
10.4.1.3. Rest of Middle East and Africa
10.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)
11. Company Profile
11.1. AstraZeneca plc
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Cubist Pharmaceuticals (Adolor Corporation)
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Daiichi Sankyo Co., Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Ironwood Pharmaceuticals, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Pfizer, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Progenics Pharmaceuticals, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Salix Pharmaceuticals Ltd.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Shionogo & Co., Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Sucampo Pharmaceuticals, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Synergy Pharmaceuticals, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
List of Figures
Figure 1 Global Opioid Induced Constipation Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Opioid Induced Constipation Drugs Market: Quality Assurance
Figure 5 Global Opioid Induced Constipation Drugs Market, By Drug Type, 2021
Figure 6 Global Opioid Induced Constipation Drugs Market, By Prescription Type, 2021
Figure 7 Global Opioid Induced Constipation Drugs Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Opioid Induced Constipation Drugs Market, 2021
Figure 9 Market Positioning of Key Opioid Induced Constipation Drugs Market Players, 2021
Figure 10 Global Opioid Induced Constipation Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 12 See Saw Analysis
Figure 13 PETEL Analysis
Figure 14 Key Buying Criteria: Current and Long-Term Perspective
Figure 15 Global Opioid Induced Constipation Drugs Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 16 Heptalysis Analysis: Global Opioid Induced Constipation Drugs Market
Figure 17 Five Whys Analysis
Figure 18 Global Opioid Induced Constipation Drugs Market, By Drug Type, 2021 Vs 2030, %
Figure 19 Global Opioid Induced Constipation Drugs Market, By Prescription Type, 2021 Vs 2030, %
Figure 20 U.S. Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 21 Canada Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 22 Rest of North America Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 23 UK Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 24 Germany Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 25 Spain Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 26 Italy Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 27 France Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 28 Rest of Europe Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 29 China Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 30 Japan Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 31 India Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 32 Australia Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 33 South Korea Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 34 Rest of Asia Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 35 Brazil Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 36 Mexico Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 37 Rest of Latin America Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 38 GCC Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 39 Africa Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 40 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market (US$ Million), 2020 - 2030List of Tables
Table 1 Global Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 2 Global Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 3 Global Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 4 North America Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 5 North America Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 6 North America Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 7 U.S. Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 8 U.S. Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 9 U.S. Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 10 Canada Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 11 Canada Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 12 Canada Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 13 Rest of North America Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 14 Rest of North America Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 15 Rest of North America Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 16 UK and European Union Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 17 UK and European Union Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 18 UK and European Union Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 19 UK Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 20 UK Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 21 UK Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 22 Germany Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 23 Germany Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 24 Germany Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 25 Spain Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 26 Spain Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 27 Spain Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 28 Italy Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 29 Italy Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 30 Italy Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 31 France Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 32 France Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 33 France Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 34 Rest of Europe Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 35 Rest of Europe Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 36 Rest of Europe Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 37 Asia Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 38 Asia Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 39 Asia Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 40 China Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 41 China Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 42 China Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 43 Japan Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 44 Japan Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 45 Japan Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 46 India Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 47 India Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 48 India Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 49 Australia Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 50 Australia Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 51 Australia Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 52 South Korea Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 53 South Korea Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 54 South Korea Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 55 Latin America Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 56 Latin America Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 57 Latin America Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 58 Brazil Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 59 Brazil Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 60 Brazil Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 61 Mexico Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 62 Mexico Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 63 Mexico Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 64 Rest of Latin America Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 65 Rest of Latin America Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 66 Rest of Latin America Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 67 Middle East and Africa Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 68 Middle East and Africa Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 69 Middle East and Africa Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 70 GCC Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 71 GCC Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 72 GCC Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 73 Africa Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 74 Africa Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 75 Africa Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Table 76 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 77 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market By Prescription Type, 2020-2030, USD (Million)
Table 78 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market By Prescribed, 2020-2030, USD (Million)
Companies Mentioned
- AstraZeneca plc
- Cubist Pharmaceuticals (Adolor Corporation)
- Daiichi Sankyo Co. Ltd.
- Ironwood Pharmaceuticals Inc.
- Pfizer Inc.
- Progenics Pharmaceuticals Inc.
- Salix Pharmaceuticals Ltd.
- Shionogo & Co. Ltd.
- Sucampo Pharmaceuticals Inc.
- Synergy Pharmaceuticals Inc
